SENSEX 80737.51 (-0.78)
Nifty 50 24542.5 (-0.70)
Nifty Bank 55599.95 (-0.54)
Nifty IT 36814.9 (-0.67)
Nifty Midcap 100 57517.1 (-0.45)
Nifty Next 50 66671.8 (-0.55)
Nifty Pharma 21354.2 (-0.19)
Nifty Smallcap 100 18114.15 (0.10)
NIKKEI 225 37743.03 (0.79)
HANG SENG 23512.49 (1.53)
S&P 5998 (0.08)
BSE Code : 524404 | NSE Symbol : MARKSANS | ISIN : INE750C01026 | Industry : Pharmaceuticals |
Hot Pursuit 30-May-2025 (09:33) Marksans Pharma gets regulatory nod for marketing type-2 diabetes medication in UK
Corporate News 30-May-2025 (09:13) Relonchem receives marketing authorization for Metformin Hydrochloride 500mg/ 5 ml Oral Solution in UK
Corporate News 20-May-2025 (12:49) Board of Marksans Pharma recommends final dividend
Results 20-May-2025 (07:46) Marksans Pharma consolidated net profit rises 15.66% in the March 2025 quarter
Corporate News 19-May-2025 (13:29) Relonchem receives marketing authorization for Sennosides 7.5 mg tablets
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others